Ethyl Acetate

Ethyl Acetate

SCHEMBL3423313

C1CCOCC1.C1CCOCC1.CCOC(C)=O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.61
LMNA P02545 4/20 0.61
HSD17B10 Q99714 1/20 0.61
TSHR P16473 3/20 0.47
POLB P06746 1/20 0.44
RECQL P46063 1/20 0.43
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 2/20 0.37
APOBEC3A P31941 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL28106135 1.00 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRPOLB
Cyclohexane SCHEMBL11112885 1.00 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL1057423 1.00 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL16332300 0.98 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL3776197 0.98 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL15194119 0.98 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL130336 0.98 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL6544884 0.98 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL3909115 0.96 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRPOLB
Ethyl Acetate SCHEMBL1873691 0.96 ALDH1A1 (0.61) ALDH1A1LMNAHSD17B10TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276524-B2 Pyridyl alkane acid amides as cytostatics and immunosuppressives ASTELLAS DEUTSCHLAND GMBH (DE) 2007-10-02 US claimed
EP-0934309-B1 NEW PYRIDYL ALKANE ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES FUJISAWA DEUTSCHLAND GMBH (DE) 2002-09-11 EP claimed
WO-2025214798-A1 FIBRE REACTIVE BROWN DYES DYSTAR COLOURS DISTRIBUTION GMBH (DE) 2025-10-16 WO disclosed
EP-4632016-A1 FIBRE REACTIVE BROWN DYES DyStar Colours Distribution GmbH (DE) 2025-10-15 EP disclosed
CN-112334191-B Pharmaceutically effective compounds for selectively inhibiting myosin 2 isoforms 普林特商业服务有限公司 2024-12-10 CN disclosed
CN-117924285-A Pharmaceutically effective compounds for selectively inhibiting myosin 2 isoforms 普林特商业服务有限公司 2024-04-26 CN disclosed
CN-117603384-A Narrow-distribution copolymer of 4-hydroxystyrene and acrylic acid derivative, and preparation method and application thereof 上海八亿时空先进材料有限公司 2024-02-27 CN disclosed
EP-2861673-B1 METAL FREE REACTIVE DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE DYSTAR COLOURS DISTRIB GMBH (DE) 2023-08-09 EP disclosed
EP-3106523-B1 METHOD FOR PRODUCING PHENYL PROPANE-BASED COMPOUND USING MICRO-ORGANISMS JAPAN AGENCY MARINE EARTH SCI (JP) 2021-06-23 EP disclosed
US-10227491-B2 Fluorescent reactive dyes, process for the production thereof and their use DyStar Coulors Distribution GmbH (DE) 2019-03-12 US disclosed
US-20180194943-A1 FLUORECENT REACTIVE DYES, PROCESS FOR THE PRODUCTION THEREOF AND THEIR USE DYSTAR COLOURS DISTRIBUTION GMBH (DE) 2018-07-12 US disclosed
WO-2010094415-A1 FLUORINE CONTAINING REACTIVE DYES DYSTAR COLOURS DEUTSCHLAND GMBH (DE) 2010-08-26 WO disclosed
WO-2010057830-A1 RING FLUORINATED REACTIVE DYES DYSTAR COLOURS DEUTSCHLAND GMBH (DE) 2010-05-27 WO disclosed
WO-2009138352-A2 FIBRE-REACTIVE DYSTUFFS CONTAINING A TRIFLUOROMETHYL GROUP DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) 2009-11-19 WO disclosed
US-20090041938-A1 MIXTURES OF FIBRE REACTIVE DYES PRODUCTION AND USE THEREOF DYSTAR TEXTILFARBEN GMBH & CO. DEUTSCHLAND KG (DE) 2009-02-12 US disclosed
US-6630467-B2 Therapy for drug abuse PFIZER INC. 2003-10-07 US disclosed
US-20030065173-A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy O'NEILL BRIAN T (US) 2003-04-03 US disclosed
EP-0937077-A1 PYRIDONE-FUSED AZABICYCLIC- OR CYTISINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN ADDICTION THERAPY PFIZER INC. (US) 1999-08-25 EP disclosed
WO-1998018798-A1 PYRIDONE-FUSED AZABICYCLIC- OR CYTISINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN ADDICTION THERAPY PFIZER INC. (US) 1998-05-07 WO disclosed
US-3989504-A Herbicidal composition of 3,4-dihydro-2H-pyrane-2,4-diones and methods NIPPON SODA COMPANY LIMITED (JA) 1976-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065173-A1 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy CHRNA5, CHRNA4, CHRNA10 ALDH1A1 488/4885LMNA 3252/4885HSD17B10 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.